Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 10;12(7):E868-E874.
doi: 10.1055/a-2325-3747. eCollection 2024 Jul.

Endoscopic resection in subepithelial lesions of the upper gastrointestinal tract: Experience at a tertiary referral hospital in The Netherlands

Affiliations

Endoscopic resection in subepithelial lesions of the upper gastrointestinal tract: Experience at a tertiary referral hospital in The Netherlands

Cynthia Verloop et al. Endosc Int Open. .

Abstract

Background and study aims Histological confirmation of subepithelial lesions (SELs) in the upper gastrointestinal tract remains challenging. Endoscopic resection of SELs is increasingly used for its excellent diagnostic yield and opportunity to do away with continued surveillance. In this study, we aimed to evaluate the indications, success rates and complications of different endoscopic resection techniques for SELs at a large, tertiary referral hospital in Rotterdam, The Netherlands. Patients and methods Data between October 2013 and December 2021 were retrospectively collected and analyzed. Main outcomes were R0-resection rate, en bloc resection rate, recurrence rate, and procedure-related adverse events (AEs) (Clavien-Dindo). Secondary outcomes were procedure time, need for surgical intervention, and clinical impact on patient management. Results A total of 58 patients were referred for endoscopic resection of upper gastrointestinal SELs. The median diameter of lesions was 20 mm (range 7-100 mm). Median follow-up time was 5 months (range 0.4-75.7). Forty-eight procedures (83%) were completed successfully leading to en bloc resection in 85% and R0-resection in 63%. Procedure-related AEs occurred in six patients (13%). Severe complications (CD grade 3a) were seen in three patients. The local recurrence rate for (pre)malignant diagnosis was 2%. Additional surgical intervention was needed in seven patients (15%). A total of 32 patients (67%) could be discharged from further surveillance after endoscopic resection. Conclusions Endoscopic resection is a safe and effective treatment for SELs and offers valuable information about undetermined SELs for which repeated sampling attempts have failed to provide adequate tissue for diagnosis.

Keywords: Endoscopic resection (ESD, EMRc, ...); Endoscopic ultrasonography; Endoscopy Upper GI Tract; Subepithelial lesions; Tissue diagnosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Clinical impact of endoscopic resections. GIST, gastrointestinal stromal tumor; NET, neuroendocrine tumor; R0, pathological radical resection; R1, pathological irradical resection.

References

    1. Humphris JL, Jones DB. Subepithelial mass lesions in the upper gastrointestinal tract. J Gastroenterol Hepatol. 2008;23:556–566. doi: 10.1111/j.1440-1746.2007.05232.x. - DOI - PubMed
    1. Faulx AL, Kothari S, Acosta RD et al.The role of endoscopy in subepithelial lesions of the GI tract. Gastrointest Endosc. 2017;85:1117–1132. doi: 10.1016/j.gie.2017.02.022. - DOI - PubMed
    1. Landi B, Palazzo L. The role of endosonography in submucosal tumours. Best Pract Res Clin Gastroenterol. 2009;23:679–701. doi: 10.1016/j.bpg.2009.05.009. - DOI - PubMed
    1. Joo HH, Saunders MD, Rulyak SJ et al.A prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial masses. Gastrointest Endosc. 2005;62:202–208. doi: 10.1016/s0016-5107(05)01567-1. - DOI - PubMed
    1. Chen H, Li B, Li L et al.Current status of endoscopic resection of gastric subepithelial tumors. Am J Gastroenterol. 2019;114:718–725. doi: 10.14309/ajg.0000000000000196. - DOI - PubMed